NEW YORK (GenomeWeb News) — Gene Bridges will use its recombination technology in collaboration with BASF in a genetic-engineering project using E. coli, Gene Bridges said Wednesday.
Under the agreement, Heidelberg, Germany-based Gene Bridges will use its Red/ET technology in bio-molecular engineering tasks, and BASF will perform screening and product and process development projects.
Gene Bridges said the agreement could “result in a significant acceleration” of development of particular E. coli strains.
Gene Bridges offers services, commercial licenses and kits using its recombineering technology.
The company’s Red/ET is an in vivo process that involved endogenous proofreading and repair mechanisms of bacterium cells, and is used in genetic engineering. It allows base specific insertion or excision of DNA fragments at selected points on the E. coli genome.